http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010508254-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06 |
| filingDate | 2007-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2010508254-A |
| titleOfInvention | Tuberculosis preventive vaccine |
| abstract | PROBLEM TO BE SOLVED: To prepare an immunotherapeutic agent containing a cell wall fragment of a toxic strain of MTB-C and thereby prepare a preventive therapeutic agent for tuberculosis caused by M. tuberculosis. In the use of an immunotherapeutic agent comprising a cell wall fragment of a toxic strain of Mycobacterium tuberculosis complex (MTB-C) to produce a preventive agent for tuberculosis, the method for producing the immunotherapeutic agent comprises (A ) Culturing a virulent strain of Mycobacterium tuberculosis complex (MTB-C) in a culture period of 3 weeks or more, and (B) culturing the cell in the presence of a nonionic surfactant. Homogenizing. |
| priorityDate | 2006-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.